Premium
Transvaginal polytetrafluoroethylene mesh surgery for pelvic organ prolapse: 1‐year clinical outcomes
Author(s) -
Kawaguchi Shohei,
Narimoto Kazutaka,
Hamuro Akihiro,
Nakagawa Tomomi,
Urata Satoko,
Kadomoto Suguru,
Iwamoto Hiroaki,
Yaegashi Hiroshi,
Iijima Masashi,
Nohara Takahiro,
Shigehara Kazuyoshi,
Izumi Kouji,
Tachibana Daisuke,
Kadono Yoshifumi,
Mizokami Atsushi,
Koyama Masayasu
Publication year - 2021
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.14444
Subject(s) - medicine , perioperative , surgery , surgical mesh , polytetrafluoroethylene , complication , stage (stratigraphy) , hernia , metallurgy , paleontology , materials science , biology
Objectives To evaluate the safety and efficacy of transvaginal mesh surgery using a polytetrafluoroethylene mesh to treat pelvic organ prolapse. Methods This prospective observational study included women undergoing transvaginal mesh surgery for pelvic organ prolapse that used new polytetrafluoroethylene mesh cut into a shape similar to that of Elevate. We evaluated the subjective and objective outcomes at 3 and 12 months, as well as postoperative complication rates. Results This study included 55 patients. The pelvic organ prolapse quantification scores improved significantly at 3 and 12 months after surgery compared with scores before surgery. In four patients (7.3%), a pelvic examination showed stage 2 objective recurrence without subjective symptoms. Clavien–Dindo grades 2 and 3 perioperative complications were observed in 9.1% and 1.8% of the patients, respectively. Vaginal mesh exposure occurred in one patient (1.8%) at the time of the 3‐month follow‐up evaluation. The mesh was exposed at the proximal midline of the anterior vaginal wall. Conclusions These findings show the safe and effective use of the polytetrafluoroethylene mesh for transvaginal mesh surgery.